Astrana Health (ASTH) FCF Margin (2010 - 2026)

Astrana Health has disclosed FCF Margin across 17 years of filings, most recently posting 6.64% for Q1 2026.

• FCF Margin for Q1 2026 came in at 6.64%, up 445.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 4.4% (up 208.0% YoY), and the FY2025 annual result was 3.28%, up 111.0% from the prior year.
• FCF Margin came in at 6.64% for Q1 2026 at Astrana Health, up from 0.63% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 21.07% in Q4 2022 to a low of 5.37% in Q3 2022.
• The 5-year median for FCF Margin is 2.84% (2022), against an average of 3.84%.
• Peak annual rise in FCF Margin reached 2876 bps in 2022, while the deepest fall reached 2394 bps in 2022.
• Astrana Health's FCF Margin stood at 21.07% in 2022, then plunged by 84 bps to 3.47% in 2023, then slumped by 158 bps to 2.03% in 2024, then jumped by 69 bps to 0.63% in 2025, then surged by 1160 bps to 6.64% in 2026.
• The last three FCF Margin figures came in at 6.64% (Q1 2026), 0.63% (Q4 2025), and 0.77% (Q3 2025), per Business Quant data.